2023 Form 5500 filing — Biocryst Pharmaceuticals, Inc. 401(K) Retirement Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20250908140136NAL0019373729001) for Biocryst Pharmaceuticals, Inc. 401(K) Retirement Plan, reported by Biocryst Pharmaceuticals, Inc. under EIN 62-1413174 and plan number 001. It reports 516 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20250908140136NAL0019373729001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Biocryst Pharmaceuticals, Inc.
- EIN
- 62-1413174
- Plan number
- 001
- Location
- Durham, NC
- Participants
- 516
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $60,305,016
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $60,305,016
- Employer contributions
- $4,436,234
- Participant contributions
- $7,181,930
- Total income / additions
- $21,700,738
- Benefits paid
- $3,823,988
- Administrative expenses
- $208,900
- Total expenses
- $4,044,144
- Net increase / (decrease)
- $17,656,594
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Erisa Smart | OTHER | $26,444 | not reported in the loaded dataset |
| Merrill Lynch, Pierce, Fenner And S | RECORDKEEPER | $4,031 | $0 |